(Q34460367)

2 August 2017

1 reference

title

Vaccine prevention of meningococcal disease, coming soon? (English)

1 reference

2 August 2017

1 reference

meningococcal disease

1 reference

1 reference

Morley SL

1

1 reference

2 August 2017

Pollard AJ

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

20

1 reference

2 August 2017

issue

5-6

1 reference

2 August 2017

page(s)

666-687

1 reference

The changing epidemiology of invasive bacterial infections in Massachusetts children, 1984 through 1991

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Bacterial meningitis in children and adults. Changes in community-acquired disease may affect patient care

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Mechanisms of neisserial serum resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Interactions of Neisseria meningitidis with human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Molecular characterization of LbpB, the second lactoferrin-binding protein of Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Microevolution and epidemic spread of serogroup A Neisseria meningitidis--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Genomic rearrangements in neisseria meningitidis strains of the ET-5 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Molecular typing methods for Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Household crowding a major risk factor for epidemic meningococcal disease in Auckland children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Meningitis outbreaks and vaccination strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Intercontinental spread of an epidemic group A Neisseria meningitidis strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Capsule switching of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Rapid serogroup switching in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Carriage of N. lactamica in a population at high risk of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Shift in the age-distribution of meningococcal disease as predictor of an epidemic?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Tobacco smoke as a risk factor for meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Influenza A and meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Complement deficiencies in selected groups of patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Assessment of complement deficiency in patients with meningococcal disease in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Meningococcemia caused by serogroup W135. Association with hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Lethal Waterhouse-Friderichsen Syndrome in Posttraumatic Asplenia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

A REPORT ON ANTIMENINGITIS VACCINATION AND OBSERVATIONS ON AGGLUTININS IN THE BLOOD OF CHRONIC MENINGOCOCCUS CARRIERS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

STUDIES ON MENINGOCOCCUS INFECTION : VIII. THE TYPE I SPECIFIC SUBSTANCE

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

The effect of variation in molecular weight on the antigenicity of dextran in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Human immunity to the meningococcus. II. Development of natural immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Quantitative Determination of the Human Immune Response to Immunization with Meningococcal Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immune Response of Human Infants to Polysaccharide Vaccines of Groups A and C Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Haemophilus influenzae type b conjugate vaccines: a review of efficacy data

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Meningococcal conjugate vaccines: new opportunities and new challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Development of Antibodies to Meningococcal Protein and Lipopolysaccharide Serotype Antigens in Healthy Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

The antimeningococcal vaccine VAMENGOC B-C induced poor serum and salivary antibody response in young Brazilian children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

The epidemiological impact of antimeningococcal B vaccination in Cuba

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Peptide mimicry of the meningococcal group C capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Effect of adjuvants in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Analysis of TbpA and TbpB functionality in defective mutants of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Serum antibodies to cross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

The immune response of children to meningococcal lipooligosaccharides during disseminated disease is directed primarily against two monoclonal antibody-defined epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immune response of infants and children to disseminated infections with Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Functional genomics of Neisseria meningitidis pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococc

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Meningococcal carriage, meningococcal disease and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

For discussion: live attenuated vaccines for group B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Production and characterization of a new monoclonal antibody against Neisseria meningitidis: study of the cross-reactivity with different bacterial genera.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Detection of antibodies to common antigens of pathogenic and commensal Neisseria species

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Candidate Neisseria meningitidis NspA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Vaccine potential of meningococcal FrpB: studies on surface exposure and functional attributes of common epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

Analysis of the human Ig isotype response to lactoferrin binding protein A from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900410-8

7 January 2021

10.1016/S0264-410X(01)00410-8

Identifiers

DOI

1 reference

2 August 2017

1 reference